CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
76 hedge funds and large institutions have $142M invested in Cascadian Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.
Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
19
Reduced
20
Closed
8
Calls
$273K
Puts
$85K
Net Calls
+$188K
Net Calls Change
+$149K